<DOC>
	<DOCNO>NCT02059018</DOCNO>
	<brief_summary>The primary objective study stimulation nitric oxide and/or prostaglandin affect diameter change retinal vessel hypoxia . Diameter change study use Dynamic Vessel Analyzer .</brief_summary>
	<brief_title>The Mechanisms Diameter Changes Retinal Vessels During Hypoxia</brief_title>
	<detailed_description />
	<mesh_term>Anoxia</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Cyclooxygenase Inhibitors</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Age &gt; 19 &lt; 61 year No know systemic ocular disease Cardiovascular disease Lung disease Epilepsy Previous ocular disease Previous treatment medication influence intraocular pressure metabolism nitric oxide prostaglandin Daily intake medicine except contraceptive pill Pregnancy breastfeed Known allergy drug use intervention</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>